This inventor holds 1 USPTO granted patent. Top assignee: Vufb A.s. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Anna Kargerova: Innovator in Antitumor Drug Development
Introduction
Anna Kargerova is a notable inventor based in Praha, Czech Republic. She has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumor compounds. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Anna Kargerova holds a patent for her invention titled "6-[X-(2-hydroxyethyl)aminoalkyl]-5,11-dioxo-5,6-dihydro-11H-indeno[-1,2-c]isochinoline derivatives." This patent describes a series of new compounds that are effective in treating malignant neoplasias in mammals. The compounds are prepared through specific chemical reactions involving indenoisochinoline derivatives and N-(hydroxyethyl)alkylen diamine in suitable solvents. The patent highlights the potential of these compounds in drug formulation and their derivatives for therapeutic applications.
Career Highlights
Anna Kargerova is associated with Vufb A.s., where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of antitumor agents and their mechanisms of action. With a focus on innovative drug development, she has established herself as a key figure in her field.
Collaborations
Anna collaborates with esteemed colleagues such as Milan Hruby and Irena Kejhova. Their combined expertise enhances the research efforts at Vufb A.s. and contributes to the advancement of new therapeutic solutions.
Conclusion
Anna Kargerova's contributions to the field of medicinal chemistry, particularly in the development of antitumor drugs, underscore her role as an innovative inventor. Her patent reflects her commitment to improving treatment options for cancer patients.